These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6464785)

  • 21. Pharmacokinetics of a single intravenous and oral dose of pafenolol--a beta 1-adrenoceptor antagonist with atypical absorption and disposition properties--in man.
    Regårdh CG; Lundborg P; Gabrielsson M; Heggelund A; Kylberg-Hanssen K
    Pharm Res; 1990 Dec; 7(12):1222-7. PubMed ID: 1982773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-performance liquid chromatographic assay of fenflumizole and its demethyl metabolites in biological samples.
    Midskov C
    J Chromatogr; 1987 Jan; 413():189-98. PubMed ID: 3558668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic studies of tolmetin in man.
    Selley ML; Glass J; Triggs EJ; Thomas J
    Clin Pharmacol Ther; 1975 May; 17(5):599-605. PubMed ID: 1126116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics and toxicology of fenflumizole, a new non-steroidal anti-inflammatory imidazole derivative.
    Corell T; Hasselmann G
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):288-96. PubMed ID: 6650179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam.
    Greenblatt DJ; Schillings RT; Kyriakopoulos AA; Shader RI; Sisenwine SF; Knowles JA; Ruelius HW
    Clin Pharmacol Ther; 1976 Sep; 20(3):329-41. PubMed ID: 8232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.
    Chen TL; Vogelsang GB; Petty BG; Brundrett RB; Noe DA; Santos GW; Colvin OM
    Drug Metab Dispos; 1989; 17(4):402-5. PubMed ID: 2571480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medroxyprogesterone acetate pharmacokinetics following oral high-dose administration in humans: a bioavailability evaluation of a new MPA tablet formulation.
    Johansson ED; Johansen PB; Rasmussen SN
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):311-7. PubMed ID: 2943134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man.
    Breimer DD; de Boer AG
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):169-78. PubMed ID: 9299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, pharmacokinetics, and pharmacodynamics of CHF 3381, a novel N-methyl-D-aspartate antagonist, after single oral doses in healthy subjects.
    Tarral A; Dostert P; Guillevic Y; Fabbri L; Rondelli I; Mariotti F; Imbimbo BP
    J Clin Pharmacol; 2003 Aug; 43(8):901-11. PubMed ID: 12953347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris.
    Grauholt AM; Grande P; Wadt J
    Eur J Clin Pharmacol; 1987; 31(5):547-51. PubMed ID: 2951260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of fenflumizole on platelet aggregation in man.
    Grande P; Wadt J; Corell T
    Eur J Clin Pharmacol; 1984; 27(2):169-72. PubMed ID: 6437841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and oral bioavailability of scopolamine in normal subjects.
    Putcha L; Cintrón NM; Tsui J; Vanderploeg JM; Kramer WG
    Pharm Res; 1989 Jun; 6(6):481-5. PubMed ID: 2762223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
    Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
    Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of lorcainide in man: a new antiarrhythmic agent.
    Klotz U; Müller-Seydlitz P; Heimburg P
    Clin Pharmacokinet; 1978; 3(5):407-18. PubMed ID: 699462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
    Harper P; Elwin CE; Cederblad G
    Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single dose pharmacokinetics of doxepin in healthy volunteers.
    Virtanen R; Scheinin M; Iisalo E
    Acta Pharmacol Toxicol (Copenh); 1980 Nov; 47(5):371-6. PubMed ID: 7293791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man.
    Ishizaki T; Nomura T; Abe T
    J Pharmacokinet Biopharm; 1979 Aug; 7(4):369-81. PubMed ID: 512843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic properties of ethosuximide in monkeys. I. Single-dose intravenous and oral administration.
    Patel IH; Levy RH; Bauer TG
    Epilepsia; 1975 Dec; 16(5):705-16. PubMed ID: 816644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.